Here we describe the successful synthesis of cyclic ADP-4-thioribose (cADPtR, 3), designed as a stable mimic of cyclic ADP-ribose (cADPR, 1), a Ca 2+ -mobilizing second messenger, in which the key N1--thioribosyladenosine structure was stereoselectively constructed by condensation between the imidazole nucleoside derivative 8 and the 4-thioribosylamine 7 via equilibrium in 7 between the -anomer (7 ) and the -anomer (7 ) during the reaction course. cADPtR is, unlike cADPR, chemically and biologically stable, while it effectively mobilizes intracellular Ca 2+ like cADPR in various biological systems, such as sea urchin homogenate, NG108-15 neuronal cells, and Jurkat T-lymphocytes. Thus, cADPtR is a stable equivalent of cADPR, which can be useful as a biological tool for investigating cADPR-mediated Ca 2+ -mobilizing pathways.
INTRODUCTION
Cyclic ADP-ribose (cADPR, 1, Fig. 1 ), a metabolite of NAD + (nicotinamide adenine dinucleotide), was originally isolated from sea urchin by Lee and co-workers (Clapper et al., 1987) . cADPR mobilizes intracellular Ca 2+ in various mammalian cells, such as, pancreatic -cells, smooth muscle, cardiac muscle, T-lymphocytes, and cerebellar neurons, and therefore, cADPR is now recognized as a general mediator of intracellular Ca 2+ signaling (Galione, 1993; Lee, 1997; Galione et al., 1998; Guse, 1999; Higashida et al., 2001; Lee, 2002; Guse, 2004; Zhang and Li, 2006; Jin et al., 2007; Venturi et al., 2010; .
Analogs of cADPR have been extensively designed and synthesized, since they are potentially useful for investigating the mechanism of cADPR-mediated Ca 2+ release Lee et al., 1993; Zhang and Sih, 1995; Ashamu et al., 1995; Wagner et al., 2003 Wagner et al., , 2005 Moreau et al., 2006 Moreau et al., , 2012 Galeone et al., 2002; Huang et al., 2002; Gu et al., 2004; Xu et al., 2006; Swarbrick and Potter, 2012; Yu et al., 2012; Shuto et al., 1998; Fukuoka et al., 2000; Shuto et al., 2001; Shuto et al., 2003; Kudoh et al., 2005; Kudoh et al., 2008; Zhang et al., 1999; Shuto and Matsuda, 2004; Guse, 2004; Potter and Walseth, 2004) . cADPR analogs are also expected to be lead structures for the development of potential drug candidates, due to the important physiological roles of cADPR (Galione, 1993; Lee, 1997; Galione 1998; Guse, 1999; Higashida et al., 2001; Lee, 2002; Guse, 2004; Jin et al., 2007; Venturi et al., 2010; . cADPR analogs have been synthesized predominantly by enzymatic and chemo-enzymatic methods using ADP-ribosyl cyclasecatalyzed cyclization under mild conditions Lee et al. 1993; Zhang and Sih, 1995; Ashamu et al., 1995; Wagner et al., 2003 Wagner et al., , 2005 Moreau et al., 2006 Moreau et al., , 2012 . The analogs obtained by these methods, however, are limited due to the substrate-specificity of the ADP-ribosyl cyclase (Zhang et al., 1999; Shuto and Matsuda, 2004; Guse, 2004; Potter and Walseth, 2004) .
In recent years, methods for the chemical synthesis of cADPR analogs have been studied to develop useful cADPR analogs (Galeone et al., 2002; Huang et al., 2002; Gu et al., 2004; Xu et al., 2006; Swarbrick et al., 2012; Yu et al., 2012; Shuto et al., 1998; Fukuoka et al., 2000; Shuto et al., 2001; Shuto et al., 2003; Kudoh et al., 2005; Kudoh et al., 2008; Zhang et al., 1999; Shuto et al., 2004; Gusu et al., 2004; Potter et al., 2004) . Construction of the characteristic pyrophosphate-containing 18-membered ring structure is the key to the synthesis of cADPR and its analogs, and we have developed an efficient method for forming the ring using S-phenyl phosphorothioate-type substrates, which can be effectively activated by Ag + or I 2 (Fukuoka et al., 2000; Shuto et al., 2001) .
cADPR is readily hydrolyzed at the unstable N1-ribosyl linkage to produce ADP-ribose (ADPR), even in neutral aqueous solution . This is due to the fact that cADPR is in a zwitterionic form positively charged around the N1-C6-N 6 moiety (pK a = 8 3), making the molecule unstable, where the charged adenine moiety attached to the anomeric carbon of the N1-linked ribose is able to be an efficient leaving group. Under physiological conditions, cADPR is also hydrolyzed at the same N1-ribosyl linkage by cADPR hydrolase to give the inactive ADPR .
We previously designed and synthesized cyclic ADPcarbocyclic-ribose (cADPcR, 2) as a stable mimic of cADPR, in which the oxygen atom in the N1-ribose ring of cADPR is replaced by a methylene group. cADPcR is both chemically and biologically stable, and effectively mobilizes intracellular Ca 2+ in sea urchin eggs (Shuto et al., 2001) . Although cADPcR is more potent than cADPR in neuronal cells , it is almost inactive in T cells, whereas natural cADPR effectively mobilizes Ca 2 in both neuronal cells and T cells Kudoh et al., 2005) .
Although intensive studies of the signaling pathway that uses cADPR are still needed because of its biological importance, the biological as well as chemical instability of cADPR limits further studies of its physiological role. Therefore, stable analogs of cADPR exhibiting Ca 2+ -mobilizing activity in various cells including T cells are required. Thus, we newly designed and synthesized a 4-thioribose-containing analog of cADPR, i.e., cyclic 3) , in which the N1-ribose of cADPR is replaced by a 4-thioribose. Evaluations in several biological systems revealed that cADPtR is a stable equivalent of cADPR, which mobilizes intracellular Ca 2+ not only in sea urchin eggs and neuronal cells, but also in T cells. Here we report the detailed results of these studies on cADPtR.
RESULTS AND DISCUSSION
Design of cADPtR cADPR is in an equilibrium between the N 6 -protonated amino-form and the N 6 -deprotonated imino-form, as shown in Figure 2 (Lee et al., 1989; Kim et al., 1993; Lee et al., 1994; Gu and Sih, 1994; Wada et al., 2005; Wada and Pope, 2001; Graham et al., 2004) . One difference between cADPR and cADPcR is their pK a values for protonation at the N 6 -position. The pK a of cADPcR (8.9) is somewhat higher than that of cADPR (8.3) (Kim et al., 1994) , which might affect its interaction with target proteins. Under physiological conditions, cADPR is in a mixture of the protonated amino form and the deprotonated imino form, where most of cADPcR should be present in the amino-form due to its relatively higher pK a . If cADPR binds to the target protein in T cells in the imino-form, activity of cADPcR would be decreased. In recent years, cADPR analogs with a hypoxanthine base instead of an adenine base, such as cyclic IDP-ribose (cIDPR, 4, Fig. 1 and these hypoxanthine-type analogs also mobilized Ca 2+ in T cells, while they were almost inactive in other biological sytems (Moreau et al., 2006; Huang et al., 2002; Gu et al., 2004; Xu et al., 2006) . These findings support the idea of an active imino-form of cADPR in T cells, because the C6 O 6 moiety might work as a bioisostere of the plane C6 N 6 moiety of the imino-form of cADPR, due to their analogous unsaturated -electronic structural features.
Another difference between cADPR and cADPcR might be their three-dimensional structures. In nucleosides, conformation around the glycoside linkage is one of the determinants of their biological activities, and they generally prefer a conformation that avoids steric repulsion between the nucleobase and sugar moieties (Saenger, 1983) . Therefore, in cADPR and its analogs, the most stable conformation can be the one with minimal steric repulsion between the adenine moiety and both of the N1-and N9-ribose moieties. It should be noted that, in cADPcR, the hydrogens on the tetrahedral sp 3 -C6 -, particularly the H6 -, which is absent in cADPR, are rather sterically repulsive to the adenine H2 (Fig. 3) . Accordingly, the stable conformation of cADPcR would differ from that of cADPR due to the steric effects (Kudoh et al., 2008) .
Taking these considerations into account, we newly designed cADPtR, a 4-thioribose analog of cADPR. 4 -Thionucleosides are recognized as useful bioisosteres of the natural nucleosides, which are extensively used in studies of medicinal chemistry and chemicalbiology (Reist et al., 1964; Bobek and Whistler, 1970; Dyson et al., 1991; Bellon et al., 1993; Yoshimura et al., 1997; Naka et al., 2000; Takahashi et al., 2009) . The 4-thioribose in 4 -thionucleosides does not only effectively mimics the ribose of nucleosides, but also the N-4-thioriobyl linkage is more stable than the corresponding N-ribosyl linkage against both chemical and enzymatic hydrolysis (Elzagheid et al., 1999; Toyohara et al., 2003) . In addition, the pK a value of cADPtR is expected to be similar to that of cADPR due to the electron-withdrawing property of sulfur atom. This type of pK a adjustment of biologically active compounds by replacing a methylene with a sulfur has been reported previously (Ganellin and Owen, 1977) . Furthermore, the conformation of cADPtR, particularly spatial positioning of the N1-thioribose and adenine moieties, would be similar to that of cADPR, because both sulfur and oxygen have a similar sp 3 configuration bearing two non-bonding electron pairs. Thus, we expected that cADPtR might be a stable cADPR equivalent that is active in various cells including T cells.
Synthetic Plan
The retrosynthetic scheme for the target cADPtR (3) is shown in Figure 4 . For the synthesis of cADPtR, construction of the 18-membered pyrophosphate structure is an important step. The structure was likely to be constructed using the intramolecular condensation reaction with an S-phenyl phosphorothioate-type substrate that we developed (Fukuoka et al., 2000; Shuto et al., 2001) , which has been effectively used in the synthesis of a variety of cADPR analogs (Galeone et al., 2002; Huang et al., 2002; Gu et al., 2004; Xu et al., 2006; Swarbrick et al., 2012; Yu et al., 2012) . Thus, treatment of the S-phenyl phosphorothioate-type substrates 5 having the N1-4-thioribosyladenosine structure with AgNO 3 /MS3A as a promoter (Fukuoka et al., 2000; Shuto et al., 2001) would form the desired cyclization product, and subsequent deprotection would furnish the target cADPtR. The S-phenyl phosphorothioate-type substrates 5 would be obtained from the N1--thioribosyl adenosine derivative 6 , which we planned to construct by condensation between the 4-thioribosylamine 7 and a known imidazole nucleoside derivative 8 (Hutchinson et al., 1997) readily prepared from inosine. The 4-thioribosylamine 7 was expected to be prepared from the 1-deoxy-4-thioribose derivative 9, obtained by a known method (Jeong et al., 2006) .
In this synthetic plan, we first had to achieve stereoselective construction of the N1--thioribosyladenosine structure. Although no 4-thioribse derivatives having an anomeric amino function such as 7 have been reported to date, 4-thioribosylamine 7 is likely to be present as an anomeric mixture, due to the electron-donating property of the hemiaminal ether nitrogen attaching at the anomeric position. We speculated that if the 4-thioribosylamine derivative 7 is indeed in equilibrium between the -anomer (7 ) and the -anomer (7 ), stereoselective construction of the N1--thioribosyladenosine structure might be achieved. In the 4-thioribosylamine 7, the -face would be rather sterically more hindered than the -face due to its rigid 5,5-cis ring system. Thus, as shown in Figure 5 , in the condensation reaction, the -anomer 7 might preferentially react with the imidazole nucleoside 8, while the -anomer 7 might not react due to the steric hindrance by the adjacent isopropylidene moiety. Thus, we expected that, in the reaction course, the relatively less reactiveanomer would not undergo the condensation, but rather would be effectively converted into the more reactiveanomer via the equilibrium to result in accumulation of the desired -condensation product 6 .
Synthesis
The 4-thioribosylamine 7 was prepared from the known 1-deoxy-4-thioribose derivative 9 (Jeong et al., 2006) , as shown in Scheme 1. While several procedures for synthesizing 4-thioribose derivatives have been reported (Reist et al., 1964; Bobek and Whistler, 1970; Dyson et al., 1991; Bellon et al., 1993; Yoshimura et al., 1997; Naka et al., 2000; Takahashi et al., 2009) , we selected the procedure recently developed by Jeong and co-workers (Jeong et al., 2006) , which is effective for large scale preparation of the 4-thio-1-deoxyribose derivative 9 having the desired 2,3-O-isopropylidene protecting group. Oxidation of 9 with m-CPBA and subsequent heating of the resulting sulfoxide product in Ac 2 O to initiate the Pummerer rearrangement afforded the 1-acetoxy product 11 as an anomeric mixture ( / = 1:5). When the anomeric mixture 11 was treated with TMSN 3 and SnCl 4 in CH 2 Cl 2 , the -azide 12 was obtained stereoselectively in high yield, probably due to the steric demand of the reaction intermediate. Reduction of the azido group of 12 by catalytic hydrogenation, followed by removal of the O-acetyl group by heating it in MeOH gave the 4-thioribosylamine 7, which appeared to be an anomeric mixture ( / = 1:2) as we expected.
We next investigated the key condensation between the 4-thioribosylanine 7 ( / = 1:2) and the imidazole nucleoside 8 under various conditions. Under basic reaction conditions, i.e., K 2 CO 3 /MeOH which was previously used to construct the N1-carbocyclic-ribosyladenine structures (Shuto et al., 2001) , the desired -condensation product 6b was actually obtained stereoselectively in 50% yield. Under the conditions, however, the N 6 -(4-thioribosy) product 13 via a Dimroth rearrangement was also obtained in 28% yield. As a result, we found that when 7 was treated with 8 (2.1 eq) in MeOH at room temperature without any bases, the -product 6b was obtained in 61% yield concomitant with 5% of the -product 6a, where the 4-thioribosylamine 7 was recovered in 17% yield (Scheme 2). Thus, the desired -product 6b was successfully obtained in 73% conversion yield from the 4-thioribosylamine ( / = 1:2) via the / -equilibrium, as we hypothesized. In the reaction conditions, the N 6 -thioribosyl product 13 (4%) was also obtained.
The N1-substituted structures of 6a and 6b was confirmed based on their HMBC spectra, in which correlation between the H2 of the adenine and the C1 of the 4-thioribose moiety was observed. The -andstereochemistries of 6a and 6b were confirmed by NOE data (see Fig. 11 ).
Conversion of the N1--thioribosyl product 6b into the S-phenyl phosphorothioate-type substrate 5 was next investigated (Scheme 3). The 5 -hydroxy group of 6b was protected with a dimethoxytrityl (DMTr) group, and then the 5 -O-TBS group of the product 14 was removed with TBAF to give 15. Treatment of 15 with an S,S -diphenylphosphorodithioate (PSS)/2,4,6-triisopropylbenzenesulfonyl chloride (TPSCl)/ pyridine system (Sekine et al., 1985; Sekine and Hata, 1993) , followed by removal of the 5 -O-DMTr group of the product 16 with aqueous AcOH gave the 5 -bis-S-(phenyl)phosphorothioate 17.
We next examined phosphorylation of the 5 -hydroxyl of 17. However, treatment of 17 under the usual conditions of Yoshikawa's phosphorylation procedure with POCl 3 /(EtO) 3 PO (Yoshikawa et al., 1969) , which was effective in the previous synthesis of cADPcR and its analogs, gave none of the desired phosphorylation product 18.
Difficulties in the phosphorylation of the 4-thioribose moiety could be assumed to occur, at least partially, because phosphorylation of the 5 -primary hydroxyl of 4 -thioribnucleoside derivatives is rather difficult compared to the cases with usual ribonucleosides (Hancox and Walker, 1996; Alexandova et al., 1996) . Walker and coworkers reported that phosphorylation of 4 -thiothymidine by Yoshikawa's procedure did not give the desired corresponding 5 -O-phosphate product. They suggested that elimination of the dichlorophosphate moiety would occur in an intermediate A due to effective neighboring group participation by the nucleophilic ring sulfur to result in reproducing the starting material 4 -thiothymidine, via a thionium intermediate B and its subsequent hydrolysis, as shown in Scheme 4(a) (Hancox and Walker, 1996) .
We thought that a zwitterionic phosphorylating reagent intermediate C, the leaving ability of the phosphate moiety would be decreased due to the negatively charged oxygen. Thus, when 17 was treated with 19 in pyridine at −30 C and then the reaction was quenched with triethylammonium acetate (TEAA) buffer, a compound likely to be the desired phosphorylated 18 was detected as a main peak by HPLC analysis. The product, without purification, was further treated with H 3 PO 2 and Et 3 N in pyridine to remove the phenylthio group (Hata et al., 1987) affording the phosphorylation product 5 after purification by ion-exchange chromatography (Scheme 5).
With the S-phenyl phosphorothioate 5 in hand, we next investigated the intramolecular cyclization reaction. When a solution of 5 in pyridine was slowly added to a mixture of a large excess of AgNO 3 and Et 3 N in the presence of MS3A in pyridine at room temperature (Fukuoka et al., 2000; Shuto et al., 2001) , the desired cyclization product 19 was obtained in 76% yield. Finally, removal of the isopropylidene groups of 19 with aqueous HCO 2 H produced the target cADPtR (3) in 49% yield (Scheme 5).
Scheme 5. Synthesis of cADPtR (3).
Stability of cADPtR cADPtR (3) appeared to be rather chemically stable, since the final acidic removal of the isopropylidene groups of 20 was successful to produce cADPtR, as described above (Scheme 5).
The biological stability of cADPtR was investigated with a rat brain microsomal extract that contains cADPR degradation enzymes . We first treated cADPR with the extract at 37 C to result in its rapid degradation. As expected, under the same conditions, cADPtR was almost completely resistant to degradation in the extract. After 120 min treatment, approximately 90% of cADPR disappeared, whereas most of cADPtR remained intact, indicating that cADPtR is stable under physiological conditions (see Fig. 12 ).
pK a Value of cADPtR
The pK a value of cADPtR (3) was determined using a previously reported method (Kim et al., 1993) . This method is based on the pH-dependent UV spectral change between 285 nm and 300 nm area of cADPR or its analogs, due to the protonation and proton-dissociation at the N 6 position of the adenine ring. As a result, the pK a of cADPtR was determined to be 8.0, which was similar to that of cADPR (pK a = 8 3) (Kim et al., 1993) and about 1 unit lower than that of cADPcR (pK a = 8 9) .
Ca

2+ -Mobilizing Activity in Sea Urchin Egg Homogenate
We tested the Ca 2+ -mobilizing ability of cADPtR (3) as well as cADPR (1) and cADPcR (2) by fluorometrically monitoring Ca 2+ with H. pulcherrimus sea urchin egg homogenate (Fig. 6) (Shiwa et al., 2002) . cADPR released Ca 2+ from the homogenate in a concentration-dependent manner with an EC 50 value of 214 nM, and cADPcR showed more potent activity (EC 50 = 54 nM) than cADPR, where the maximal Ca 2+ -mobilizing activity of cADPcR was almost equal to that of cADPR. These results are consistent with previous reports that cADPcR potently activates Ca 2+ release in sea urchin eggs of A. crassispina or L. pictus (Shuto etal., 2001; Kudoh et al., 2008) . As shown in Figure 6 , cADPtR exhibited highly potent Ca 2+ -mobilizing ability (EC 50 = 36 nM), which was about 7-fold more potent than the natural second messenger cADPR and even more potent than cADPcR.
Ca
2+ -Mobilizing Activity in Neuronal Cells
The effect of cADPtR (3) on cytosolic Ca 2+ mobilization in NG108-15 neuronal cells was studied in permeabilized conditions using digitonin as the detergent (Higashida et al., 1990; Amina et al., 2010 not cause an increase in [Ca 2+ ] i in the conditions in which the plasma membrane was permeabilized with 250 nM of digitonin for nearly 5 min (Figs. 7(b) and (c)). We also confirmed that application of 100 mM cADPR (1), used as a positive control, caused a gradual and sustained Ca 2+ release in the digitonin-permeabilized conditions, which allowed nucleotides to enter into the cytoplasm (Fig. 8(c) ). When cADPR was applied extracellularly to intact NG108-15 cells, no increase in [Ca 2+ ] i was detected (data not shown). ] i level measured 4 min after application of cADPtR was 116 ± 2.3% of the resting (pre-permeabilization) level (mean ± SEM; n = 6). The amplitude evoked by cADPtR was equivalent to or significantly greater than that induced by cADPR: the mean [Ca 2+ ] i level measured 4 min after application of cADPR was 107 ± 2.8% of the resting level (n = 10). A similar Ca 2+ -mobilizing pattern was observed in cADPcR-applied cells: the mean [Ca 2+ ] i level measured 4 min after application of cADPcR was 115 ± 3.1% of the resting level (n = 10).
These results in NG108-15 neuronal cells indicate that cADPtR has potent Ca 2+ -mobilizing activity, similar to cADPcR. Both cADPtR and cADPcR have increased efficacy as compared with cADPR, which may be due to their increased metabolic stability.
Ca
2+ -Mobilizing Activity in T Cells
The Ca 2+ -mobilizing effect of cADPtR (3) was evaluated using saponin-permeabilized Jurkat T cells as reported previously (Guse et al., 1993; Guse et al., 2007; Schwarzmann et al., 2002) . Both cADPtR and cADPR (1) evoked rapid Ca 2+ release upon addition to the permeabilized cell suspension indicating similar mechanisms of Ca 2+ release ( Fig. 8(a) ). Though cADPR was somewhat more potent at 100 mM, cADPR and cADPtR had very similar concentration-response curves (Fig. 8(b) ) indicating that cADPtR binds to the cADPR receptor protein with similar affinity. Our previous work revealed that replacing the northern ribose of cADPR with the carbocyclic moiety (cADPcR) shifted its Ca 2+ mobilizing activity to much higher concentrations ). In contrast, the new analog cADPtR was almost as active as cADPR. A difference of cADPcR and analog cADPtR are their pK a values, amounting to 8.9 and 8.0, respectively. Taking the pK a value of cADPR and the indistinguishable biological activity between cIDPR (4) and cADPR (Moreau et al., 2006; Huang et al., 2002; Gu et al., 2004; Xu et al., 2006) in T cells into account, the relatively high biological activity of cADPtR might be in favour of the imino form of cADPR being the active form of the natural second messenger in T cells.
Conformational Analysis
The three-dimensional structures of biologically active compounds in aqueous solution is very important from the viewpoint of the bioactive conformation. Our study shows that cADPR (1), cADPcR (2), and cADPtR (3) have different activities in sea urchin eggs, neuronal cells and T cells, respectively. To investigate the biological difference based on their conformations, structures of them were constructed by molecular dynamics calculations with a simulated annealing method based on the NOE constraints of the intramolecular proton pairs measured in D 2 O (for details, see Fig. 13 ). The structures obtained by the calculations based on their observed NOE in the NOESY spectra are shown in Figure 9 .
To analyze the structural differences in more detail, these structures were superimposed as shown in Figure 10 (a), which shows that the cADPtR structure (red) resembles that of natural cADPR (blue). The cADPcR structure (green), however, is not similar to those of the other two compounds, in which the relative special arrangement of the N1-thioribose ring and the adenine ring is clearly different from those of the other two compounds, as we expected. Thus, the distances between the 4 S between the adenine H2 of cADPtR (3.6 Å) is significantly longer than the corresponding distances of cADPR (2.3 Å) and cADPtR (2.5 Å), probably due to the steric repulsion between the H6 with the adenine H2 in cADPcR.
To confirm the validity of the obtained structures, we used the cADPR structure solved by X-ray crystallographic analysis (2j, Lee et al., 1994 ] i levels at 280 s after membrane permeabilization, represented by fluorescence intensity at each time divided by the resting state at time 0 (i.e., F x /F 0 ). Each symbol is mean ± SEM of 5 to 10 experiments. * , values significantly different from a drug-free control value (a gray circle) (P < 0 05). , Values in cells treated with cADPtR were significantly higher than those in cells with cADPR at p < 0 05. structure of cADPR (white) is superimposed into the three structures as shown in Figure 10 (b) . This crystal structure resembles the calculated cADPR and cADPtR structures, which suggests our structure determination by the molecular dynamics calculations was done relevantly. Discussion cAPDtR (3), which was designed as a stable mimic of cADPR (1), was successfully synthesized. In its synthesis, the key N1--thioribosyladenosine structure was effectively constructed by stereoselective condensation between the imidazole nucleoside derivative 8 and the 4-thioribosylamine 7 via equilibrium between the -anomer (7 ) and the -anomer (7 ). Also, the strategy using a S-phenyl phosphorothioate-type substrate in the intramolecular condensation reaction forming the 18-membered pyrophosphate linkage of cADPR-related compounds is demonstrated to be useful in the present case.
Although cADPR is rapidly hydrolyzed by cADPR hydrolase to give ADP-ribose under physiological conditions, cADPtR was shown to be biologically stable. Based on the X-ray crystallographic analysis of the complex of CD38 having cADPR hydrolase activity with nicotinamide guanine dinucleotide (GDP + ), Lee and Hao presented the reaction mechanism of enzymatic cADPR hydrolysis via an oxocarbenium intermediate, which is stabilized by the hydroxy group of Ser196 of the enzyme catalytic site . When an oxocarbenium ion, which is often an intermediate in glycosidic bond cleavage, interacts with an electronically negative nucleophilic atom such as oxygen (the hydroxyl oxygen of Ser196 in the case of CD38), it can be effectively stabilized by the adjacent ring oxygen of the sugars due to n-p * hyperconjugation between the nonbonding orbital on the ring oxygen and the vacant p-orbital of anomeric carbon, that is known as the anomeric effect (Juaristi and Cuevas, 1992; Thatcher, 1993; Juaristi and Cuevas, 1995; Thibaudeau and Chattopadhyaya, 1999 (1) and cADPtR (3) on Ca 2+ signaling in permeabilized Jurkat T cells. After addition of fura-2/free acid (1.5 mM) and charging of the intracellular Ca 2+ -pools by the addition of ATP (1 mM) and an ATP-regenerating system consisting of creatine phosphate (10 mM) and creatine kinase (20 units/ml), the indicated concentrations of cADPR or cADP-4 -thio-ribose were added as indicated. On the other hand, the sulfur of thio-sugars, including thioribose, would not so effectively stabilize the corresponding thio-carbenium intermediates, because the hyperconjugation ability of sulfur is remarkably weaker than that of oxygen (Salzner and Salzner, 1993) , which can be reason why cADPtR is more stable than cADPR.
On the other hand, the electron-withdrawing effect of sulfur due to its electronically negative property effectively lowered the pK a of cADPtR, and accordingly, its pK a is similar to that of cADPR. Under physiological pH, the population of the deprotonated imino form and the protonated amino form in cADPtR would be analogous that Figure 9 . Structures of cADPR (a) , cADPcR (b) , cADPtR (c) by molecular dynamics calculations with simulated annealing method using the NOE data in D 2 O. Adenine H2 (white), O4 in cADPR (red), C6 in cADPcR (green) and S4 in cADPtR (yellow) are shown in sphere.
in cADPR. Therefore, the pK a value of cADPtR may be favorable to exhibit its biological effects, similarly to natural messenger cADPR.
A difference of cADPcR and analog cADPtR are their pK a values, amounting to 8.9 and 8.0, respectively. Taking the pK a value of cADPR and the indistinguishable biological activity between cIDPR (4) and cADPR (Moreau et al., 2006; Huang et al., 2002; Gu et al., 2004; Xu al., 2006) in T cells into account, the relatively high biological activity of cADPtR might be in favour of the imino form of cADPR being the active form of the natural second messenger in T cells.
Our conformational analysis revealed that cADPtR has its three-dimensional structure analogous to cADPR due the similar sp 3 configuration of oxygen and sulfur bearing two non-bonding electron pairs in the N1-ribose or -thioribose ring, in which steric repulsion between the three rings (adenine, N9-ribose, and N1-ribose) seems to be minimal. Therefore, the structural and electrostatic features of cADPtR analogous to cADPR make it as biologically active as cADPR in various systems including T -cells, although the target proteins of cADPR in these systems is considered to be different .
Conclusion
We have successfully synthesized cADPtR (3) and demonstrated that it is stable and functions as cADPR (1) in various biological systems, i.e., sea urchin egg homogenate, neuronal cells and T cells. Because of the characteristic stability and high potency of cADPtR, it, as a stable equivalent of cADPR, can be useful as an effective tool for identifying target proteins and for investigating cADPRmediated signaling pathways (Tsuzuki et al., 2013) . The crystal structure of cADPR (white), the calculated structures of cADPR (blue), cADPcR (green), and cADPtR (red).
EXPERIMENTAL DETAILS
on Merck silica gel 5715. Reactions were carried out under an argon atmosphere.
1,4-Dideoxy-1,4-Episulfinyl-2,3-O-Isopropylidene-D-Ribitol (10)
To a solution of 22 (1.90 g, 10.0 mmol) in CH 2 Cl 2 (30 mL) was added slowly a solution of mCPBA (3.18 g, 12.0 mmol) in CH 2 Cl 2 (60 mL) at −78 C, and the mixture was stirred at the same temperature for 20 min. To the mixture was added aqueous Na 2 S 2 O 3 , and the resulting mixture was partitioned between EtOAc and H 2 O, and the organic layer was washed with aqueous saturated NaHCO 3 and brine, dried (Na 2 SO 4 ), and evaporated. The residue was purified by column chromatography (SiO 2 , hexane/AcOEt = 3/1 then 1/1) to give 10 (1.88 g, 91%, white amorphous solid): 1 H-NMR of one isomer (500 MHz, CDCl 3 1.33 (3 H, s, isopropylidene-CH 3 ), 1.47 (3 H, s, 24. 61, 27.12, 57.06, 57.06, 58.11, 65.63, 79.76, 82.22, 112.11 ; HR-MS (EI) calcd for C 8 H 14 O 4 S 2 206.06128 (M + ), found 206. 06169.
A solution of 10 (135 mg, 0.44 mmol) in Ac 2 O (3 mL) was heated at 100 C for 28 h, and then evaporated. The residue was partitioned between EtOAc and H 2 O, and the organic layer was washed with aqueous saturated NaHCO 3 and brine. The aqueous layers were combined and extracted with CHCl 3 . The organic layers were combined, dried (Na 2 SO 4 ), and evaporated. The residue was purified by column chromatography (SiO 2 , hexane/AcOEt = 6/1, 3/1 then 1/1) to give 11 (93 mg, 64%, J = 11 5, 5. 85, 21.21, 24.61, 26.38, 53.85, 65.71, 85.13, 87.17, 88.54, 111.29, 169.16, 170. Figure 13 . Important correlations in NOESY spectra of (a) cADPR (1), (b) cADPcR (2), (c) cADPtR (3), used for the calculations.
same temperature for 5 min. To the mixture was added aqueous saturated NaHCO 3 , and the resulting white precipitate was filtered off with Celite. The filtrate was washed with aqueous saturated NaHCO 3 and brine, dried (Na 2 SO 4 ), and evaporated. The residue was purified by column chromatography (SiO 2 , hexane/AcOEt = 20/1) to give 12 (1.84 g, 86%, yellow oil): 1 H-NMR (400 MHz, CDCl 3 1.31 (3 H, s, 
2,3-O-Isopropylidene-4-Thio-DRibofuranosylamine (7)
A mixture of 12 (1.25 g, 4.57 mmol) and Pd/C (10%, 630 mg) in MeOH (45 mL) was stirred under atmospheric pressure of H 2 at room temperature for 1 h, and then the catalysts were filtered off with Celite. The filtrate was evaporated, and the residue was purified by column chromatography (NH-silica gel, hexane/AcOEt = 6/1, 2/1 then 1/3) to give 7 (1.09 g, quant., / = 1/2, brown oil): 18.23, 24.36, 25.27, 25.80, 26.50, 27.22, 57.20, 63.68, 64.31, 64.63, 81.06, 85.99, 86.45, 87.57, 91.20, 91.65, 95.13, 110.33, 113.74, 117.26, 132.20, 148.52, 151.04; 
A solution of 7 (381 mg, 1.87 mmol) and 8 (1.79 g, 4.00 mmol) in MeOH (10 mL) was stirred at room temperature for 10 h, and then evaporated. The residue was purified by flash column chromatography (silica gel, hexane/AcOEt = 1/2, AcOEt , then AcOEt/MeOH = 9/1) to give 6 (700 mg, 61%, white amorphous solid), 6 (59 mg, 5%, white amorphous solid), 14 (30 mg, 4%, yellow amorphous solid). (1 H, dd, J = 11 4, 4.0, 4.0 Hz, m, 3.90 (1 H, m, , 4.01 (1 H, dd, J = 11 4, 3.7 Hz, , 4.39 (1 H, m, H-4 ) , 4.88 (1 H, dd, J = 6 3, 3.4 Hz, , 4.99 (1 H, dd, J = 5 2, 1.7 Hz, H-3 ), 5.06 (1 H, dd, J = 6 3, 2.3 Hz, , 5.51 (1 H, dd, J = 5 2, 3.4 Hz, , 6.00 (1 H, d, J = 3 4 Hz, , 6.02 (1 H, d , J = 2 3 Hz, H-1 ), 7.85 (1 H, s, H-8), 7.88 (1 H, s, H-2) ; 18.25 25.25, 25.80, 27.13, 27.92, 55.53, 63.37, 64.75, 74.54, 81.19, 85.23, 85.75, 86.22, 86.95, 91.15, 111.66, 114.09, 123.75, 137.20, 140.30, 146.81, 153.31; UV (MeOH) SSi: C, 53.18; H, 7.11, N, 11.48. Found C, 52.88; H, 6.95; N, 11.35; , irradiated H-1 /observed H-4 (2.3%), irradiated H-2 / observed H-2 (4.7%), irradiated H-4 / observed H-1 (3.2%). 6 : 1 H-NMR (500 MHz, CDCl) 0.05 (3 H, s, , 0.05 (3 H, s, 0.87 (9H, s, 1.35 (3 H, s, ), 1.39 (3 H, s, ), 1.61 (3 H, s, ), 1.63 (3 H, s, , 3.56 (1 H, d, J = 4 1, 4.1 Hz, 3.76 (1 H, dd, J = 11 3, 3.6 Hz, m, 3.93 (1 H, dd, J = 10 9, 4.1 Hz, , 4.39 (1 H, ddd, J = 6 3, 3.6, 3.6 Hz, 4.90 (1 H, dd, J = 6 3, 2.7 Hz, 3 −5.54, −5.44, 18.29, 24.22, 25.33, 25.83, 25.97, 27.16, 54.36, 61.15, 63.34, 65.17, 80.59, 81.19, 85.30, 85.87, 86.99, 91.16, 111.38, 114.09, 122.77, 136.83, 140.88, 147.76, 155 (1 H, m, 3.73 (1 H, dd, J = 11 3, 4.5 Hz, m, 3.90 (1 H, br, OH) −5.51, 18.23, 24.36, 25.27, 25.80, 26.50, 27.22, 57.20, 63.68, 64.31, 64.63, 81.06, 85.99, 86.45, 87.57, 91.20, 91.65, 95.13, 110.33, 113.74, 117.26, 132.20, 148.52, 151.04 
A solution of 6 (889 mg, 1.46 mmol) and DMTrCl (989 mg, 2.92 mol) in pyridine (5 mL) was stirred at room temperature for 12 h. 3 −5.58, −5.47, 18.22, 25.21, 25.28, 25.79, 27.13, 27.35, 54.95, 55.05, 63.30, 64.85, 66.78, 81.06, 84.82, 85.25, 86.53, 86.79, 89.22, 90.86, 112.38, 113.03, 113.05, 114.01, 123.23, 126.66, 127.73, 127.95, 129.92, 129.96, 135.46, 135.60, 136.51, 140.35, 144.47, 145.55, 153.98, 158. 37 SSi: C, 63.20; H, 6.74, N, 7.68. Found C, 63.19; H, 6.91; N, 7.39 .
A solution of 14 (94 mg, 103 mmol), TBAF (1.0 M in THF, 200 mL, 0.20 mmol) and AcOH (6 L, 1 mol) in THF (800 mL) was stirred at room temperature for 9 h, and then evaporated. The residue was purified by column chromatography (silica gel, hexane/AcOEt = 2/1, / (1 H, s, H-8) , 8.14 (1 H, s, H-2); CDCl 3 25.42, 25.48, 27.60, 27.76, 54.98, 55.39, 63.28, 65.05, 67.35, 81.62, 83.90, 84.89, 86.03, 86.90, 89.28, 93.95, 112.90, 113.35, 114.39, 125.04, 127.03, 128.07, 128.26, 130.18, 130.23, 135.74, 135.92, 138.32, 139.63, 144.66, 146.01, 153.86, 158.70 
To a solution of 15 (845 mg, 1.06 mmol) in pyridine (5 mL) was added a solution of PSS (809 mg, 2.12 mmol) and TPSCl (693 mg, 1.91 mmol) in pyridine (5 mL) at −15 C, and the mixture was stirred at the same temperature for 2.5 h. To a mixture of AgNO 3 (36 mg, 0.21 mmol), Et 3 N (29 ml, 0.21 mmol), and MS 3A (powder, 1.0 g) in pyridine (8 mL), a solution of 5 (9 mg, 50 OD 260 unit, 4 mmol) in pyridine (8 mL) was added slowly over 15 h, using a syringe-pump, at room temperature under shading. To the mixture was added TEAA buffer (2.0 M, pH 7.0, 2 mL), and the resulting mixture was filtered with Celite and evaporated. The residue was partitioned between EtOAc and H 2 O, and the aqueous layer was evaporated, and the residue was purified by column chromatography (ODS, 1. The excess TEAA included in the residue was removed by column chromatography (Sephadex LH 20, 2.5 × 20 cm, H 2 O) to give 3 as a triethylammonium salt, which was converted into a free acid form by passing through columns of Daiaion PK212L (H + form, 0.7 cm × 5 cm, H 2 O). The free acid was passed throuh Chelex 100 column (K + form, 0.7 cm × 6 cm, H 2 O). The eluent was evapolated and lyophilized to give 3 (138 OD 260 unit, 49%) as a potassium salt. 8, 50.9, 63.1, 65.0, 65.0, 70.1, 70.6, 72.6, 73.0, 78.3, 84.7, 84.8, 90.5, 120.0, 145.3, 145.9, 146.9, 150.8; 31 (1 H, dd, J = 5 9, 2.9 Hz), 4.71 (1 H, dd, J = 5 2, 2.3 Hz), 5.22 (1 H, dd, J = 6 3, 5.2 Hz), 5.97 (1 H, d , J = 2 9 Hz), 6.04 (1 H, d , J = 6 3 Hz), 8.38 (1 H, s) , 9.90 (1 H, s) .
Stability in Rat Brain Microsomes
Rat brain microsomes were prepared by a procedure according to the previous method (Murayama, T. and Ogawa Y. (1996) . J. Biol. Chem. 271, [5079] [5080] [5081] [5082] [5083] [5084] . cADPR or cADPtR (1.6 OD 260 unit) was preincubated in 20 mM MOPS buffer (pH 7.1, 160 L) at 37 C for 5 min. This was added to the solution of the microsome fraction of rat brain extract (14.9 mg/mL, 140 L), and the mixture was incubated at 37 C. The reaction mixture was sampled (25 L) at every 30 min afterwards and diluted with water (175 L), which was frozen in liquid nitrogen to stop the reaction. After the samples were a centrifuged at 12000 rpm at 4 C for 15 min, the supernatants were filtered using centrifugal filter at 12000 rpm at 4 C for 15 min, and the resulting filtrates (70 L) were analyzed by ion exchange HPLC (TSK-GEL DEAE-2SW, 4.6 × 250 mm; 5-35% 1 M HCO 2 NH 4 /20% MeCN, 20 min; 260 nm). The results are shown in Figure 2 .
Biological Evaluations with Sea Urchin Egg Homogenate or T -cells
These bioassays were carried out as reported previously .
Biological Evaluations with Neuronal Cultured Cells
NG108-15 neuroblastoma x glioma hybrid cells were cultured as reported previously (Higashida et al., 1990) . Oregon Geen-loaded NG108-15 cells were incubated for 2 min in the following calcium-free medium (140 mM K-glutamate, 20 mM PIPES, 5 mM EGTA, 2 mM Mg-ATP, 10 mM glucose, 1 mM magnesium chloride, 0.01% bovine serum albumin, pH 6.8) at 37 C, and subsequently permeabilized with 250 nM digitonin in the calcium-free medium. cADPR (1-100 M), cADPcR (1-100 M), or cADPcR (1-100 M) were applied together with the digitonin-containing permeabilization buffer to be allowed free passage of these nucleotides into the cytoplasm. Concentrations of [Ca 2+ ] i were determined microspectrofluorometrically using fura-2 in differentiated NG108-15 cells cultured on polylysine-coated glass coverslips. The cells were loaded with fura-2 using 5 M Oregon Green 488 1,2-bis(2-aminophenoxy)ethane-N ,N ,N ,N -tetraacetate acetoxymethylester (BAPTA-1 AM). Fluorescence was measured at 37 C with excitation wavelengths of 485 nm and emission wavelengths of 538 nm using an Argus 50 Ca 2+ microspectrofluorometric system (Hamamatsu Photonics, Hamamatsu, Japan) and images were collected every 10 s for up to 5 min.
